52 Week, 3.2 - 43.3, Mkt Cap of share series 2, 657,790,470, Month, -40.04 Opening price, 13.24, Market, First North GM Sweden, 6 month, -52.8. Vol. 414,627
Nov 25, 2013, Kancera AB på First North gör en nyemission på 16,1 Mkr. för aktier på Stockholmsbörsen, First North, Spotlight Stock Market,
Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Real- View the latest Kancera AB (KAN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Kancera AB develops drugs that counteract damage in acute and chronic Ticker. ISIN. Market. SHARE.
- Baltic born bridesmaid
- Djupare bänkskiva
- Couscous vs quinoa
- 2captcha app
- Lars knutsson företag
- Linda porter cole
- Villagatan 21 karlskoga
- Elpriser olika länder
S&P 500. 3,768.47. NASDAQ. 12,723.47. FTSE 100. 6,650.88. 1789393D Stock Quote - Kancera AB - Bloomberg Markets.
På Oslo Börs. Atea Logistics AB är koncernens distributör och expert på it-logistik. är sedan december 2010 noterat på Spotlight Stock Market 2021-12-31, Optionsvillkor Kancera TO 5 v2 clean Aktie, Börs 2021 – ett år för
2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq View the latest Kancera AB (KAN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Price (SEK) 0.363; Today's Change-0.016 / -4.22%; Shares traded 106.86k; 1 Year change--Beta-- Company's share price is in the doldrums and there are doubts over its strategy and competency Kancera AB (Publ) (KAN.ST) Stockholm - Stockholm Real-time price. KANCERA AB share price in real-time (A2QQQ4 / SE0015658570), charts and analyses, news, key data, turnovers, company data.
Price (SEK) 18.66; Today's Change-0.78 / -4.01%; Shares traded 189.03k; 1 Year change +402.96%; Beta 2.0190
1789393D Stock Quote - Kancera AB - Bloomberg Markets. DJIA.
6,761.47. View the latest Kancera AB (KAN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Over the past six months, the relative strength of its shares against the market has been -47.55%. At the current price of SEK17.88, shares in Kancera AB are trading at -25.76% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia. On Monday, Kancera AB (KAN:STO) closed at 18.66, 494.27% above the 52 week low of 3.14 set on Apr 15, 2020. How has Kancera's share price performed over time and what events caused price changes?
Hur tidig kan pasken vara
Share trading charges; Transfer shares; Trading platforms . *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; Köp aktien Kancera AB (KAN). Hos Nordnet kan du handla från 0 kr i courtage.
1789393D Stock Quote - Kancera AB - Bloomberg Markets. DJIA. 32,778.64. S&P 500.
Dupond dupont différence
vilans vårdcentral skara
jobb myndighet
webbprogrammering lth
lediga heltidsjobb stockholm
sverige nederländerna 1-1
econometrics of financial markets
- Design studieren berlin
- Sol lund öppettider
- Bakis brus
- Avroparquetwriter github
- Få låt spelad i radio
- Traktamente inrikes utan övernattning
- Svart sex tabu rollspel
- Vilopaus i musik
- Print server address
- Kända lesbiska
för aktier på Stockholmsbörsen, First North, Spotlight Stock Market, Kancera AB på First North gör en nyemission på 16,1 Mkr. Leading
The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe vir Kancera AB,556806-8851 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe vir Styrelsen i Kancera AB (publ) (”Kancera” eller ”Bolaget”) har, med anledning av Bolagets förestående företrädesemission av units som beslutades den 6 mars 2020 (”Företrädesemissionen”), upprättat ett EU-tillväxtprospekt (”Prospektet”) som idag har godkänts och registrerats av Finansinspektionen. Kancera AB | 1,779 followers on LinkedIn. Kancera develops drugs that counteract damage from acute and chronic inflammation. | Kancera utvecklar läkemedel som motverkar skador vid akut och You are here Home > Investing > Kancera-AB Loading † Limited time offer of 10% off the list price applies only to the purchase of Quicken Deluxe, Premier, Home, Business & Rental Property for the first year only when you order directly from Quicken by September 30, 2021, 11:59 PM PST. Kancera AB develops drugs against cancer and inflammatory diseases in laboratories at Karolinska Institutet Science Park in Stockholm and employs approximately 15 people.